Wei Jiang
10Patents
3h-index
28Co-inventors
60Inventor score
Filing activity: Jul 3, 1996 → Jul 11, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5932613A | Anticancer agents | Human Necessities | 10 | Expired |
| US7456276B2 | Peptide purification by means of metal ion affinity chromatography | Performing Operations; Transporting | 9 | Expired |
| US7776597B2 | Method of inducing embryonic stem cells into pancreatic cells | Chemistry; Metallurgy | 3 | Expired |
| US6359000B1 | Anticancer agent | Human Necessities | 2 | Expired |
| US10584171B2 | Anti-epidermal growth factor receptor (EGFR) antibodies | Physics | 1 | Active |
| US12415858B2 | Anti-tigit antibodies, multispecific antibodies comprising the same, and methods of using the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US12247085B2 | Hybridoma cell line of secreting cyproheptadine monoclonal antibodies and preparation method thereof | Physics | 0 | Active |
| US11603414B2 | Hybridoma cell line that secrets cyproheptadine monoclonal antibodies and preparation method thereof | Physics | 0 | Active |
| US12172813B2 | Degradable plastic bottle, preparation method and degradation method thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8674289B2 | Isotopic abundance in atom trap trace analysis | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.